Argent Biopharma Limited has released a press release.
MGC Pharma Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Argent Biopharma
- December Quarterly Activity and Cashflow Report
- ArtemiC Phase II Clinical Trial Results
- Prospectus
- Mgc pharma completes acquisition of telehealth platform mcc
- Further successful results from glioblastoma research
Later from Argent Biopharma
- MGC Pharma first medicinal cannabis company to list on LSE
- SwissPharmaCan AG increases initial purchase order
- Ethics Committee Approval Granted Phase III Clinical Trial
- Mxc completes first artemic order, march qtr record revenue
- Investor presentation
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma